Skip to main content

We narrowed to 148 results for: GFP expression plasmids

Showing: 91 - 100 of 148 results
  1. pAAV-EF1a-mitoGFP-DIO (AAV2)

    Viral Prep
    #174112-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-EF1a-mitoGFP-DIO (#174112). In addition to the viral particles, you will also receive purified pAAV-EF1a-mitoGFP-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GFP. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Aug. 7, 2025
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-FLEX-DTR-GFP (AAV2)

    Viral Prep
    #124364-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-FLEX-DTR-GFP (#124364). In addition to the viral particles, you will also receive purified pAAV-FLEX-DTR-GFP plasmid DNA. CBA-driven, Cre-dependent expression of DTR-GFP. These AAV preparations are suitable purity for injection into animals.
    Promoter
    Chicken B-actin
    Tags
    GFP (Cre-dependent)
    Available Since
    June 16, 2020
    Availability
    Academic Institutions and Nonprofits only
  3. AAV-FLEX-Arch-GFP (AAV9)

    Viral Prep
    #22222-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from AAV-FLEX-Arch-GFP (#22222). In addition to the viral particles, you will also receive purified AAV-FLEX-Arch-GFP plasmid DNA. CAG-driven cre-dependent Arch-GFP expression for optogenetic neural inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    GFP (Cre-dependent)
    Available Since
    Feb. 20, 2018
    Availability
    Academic Institutions and Nonprofits only
  4. AAV-FLEX-Arch-GFP (AAV1)

    Viral Prep
    #22222-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from AAV-FLEX-Arch-GFP (#22222). In addition to the viral particles, you will also receive purified AAV-FLEX-Arch-GFP plasmid DNA. CAG-driven cre-dependent Arch-GFP expression for optogenetic neural inhibition. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    GFP (Cre-dependent)
    Available Since
    Feb. 21, 2018
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV_BiPVe4_eGFP (AAV1)

    Viral Prep
    #221463-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV_BiPVe4_eGFP (#221463). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_eGFP plasmid DNA. Expression of EGFP under the control of the chandelier cell-targeting enhancer E4. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    EGFP
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV-FLEX-EGFPL10a (AAV Retrograde)

    Viral Prep
    #98747-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-FLEX-EGFPL10a (#98747). In addition to the viral particles, you will also receive purified pAAV-FLEX-EGFPL10a plasmid DNA. Cre-dependent EGFPL10a (EGFP-tagged ribosomal protein) expression for translating ribosome affinity purification (TRAP). These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Promoter
    EF1a
    Tags
    EGFP (Cre-dependent)
    Available Since
    Sept. 27, 2023
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV-CAG-NLS-GFP (AAV PHP.eB)

    Viral Prep
    #104061-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-NLS-GFP (#104061). In addition to the viral particles, you will also receive purified pAAV-CAG-NLS-GFP plasmid DNA. CAG-driven NLS-GFP expression. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Tags
    GFP
    Available Since
    March 5, 2019
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV_BiPVe4_eGFP (AAV PHP.eB)

    Viral Prep
    #221463-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV_BiPVe4_eGFP (#221463). In addition to the viral particles, you will also receive purified pAAV_BiPVe4_eGFP plasmid DNA. Expression of EGFP under the control of the chandelier cell-targeting enhancer E4. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Tags
    EGFP
    Available Since
    Sept. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV-Syn-Chronos-GFP (AAV1)

    Viral Prep
    #59170-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-Syn-Chronos-GFP (#59170). In addition to the viral particles, you will also receive purified pAAV-Syn-Chronos-GFP plasmid DNA. Syn-driven Chronos-GFP expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    GFP
    Available Since
    Feb. 7, 2018
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV-Syn-Chronos-GFP (AAV5)

    Viral Prep
    #59170-AAV5
    Purpose
    Ready-to-use AAV5 particles produced from pAAV-Syn-Chronos-GFP (#59170). In addition to the viral particles, you will also receive purified pAAV-Syn-Chronos-GFP plasmid DNA. Syn-driven Chronos-GFP expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Tags
    GFP
    Available Since
    July 21, 2017
    Availability
    Academic Institutions and Nonprofits only
Showing: 91 - 100 of 148 results